Literature DB >> 26781000

Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease.

Martin I MacDonald1, Eskandarain Shafuddin2, Paul T King3, Catherina L Chang4, Philip G Bardin3, Robert J Hancox2.   

Abstract

Chronic obstructive pulmonary disease (COPD) and cardiovascular disease often coexist, and acute cardiac events frequently occur during COPD exacerbations. Even when cardiac complications are not clinically apparent, biochemical evidence of cardiac dysfunction is often noted during exacerbations and portends poor prognosis. Diagnosis of cardiac disease in COPD can be difficult and necessitates a high degree of clinical suspicion. However, the additional strain of an exacerbation could be a pivotal moment, during which previously unsuspected cardiac dysfunction is exposed. In this Review, we present evidence about cardiac involvement in exacerbations of COPD, and discuss diagnostic challenges and treatment opportunities.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26781000     DOI: 10.1016/S2213-2600(15)00509-3

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


  20 in total

1.  Clinical impact of vital sign abnormalities in patients admitted with acute exacerbation of chronic obstructive pulmonary disease: an observational study using continuous wireless monitoring.

Authors:  Helge B D Sørensen; Eske K Aasvang; Christian S Meyhoff; Mikkel Elvekjaer; Søren M Rasmussen; Katja K Grønbæk; Celeste M Porsbjerg; Jens-Ulrik Jensen; Camilla Haahr-Raunkjær; Jesper Mølgaard; Marlene Søgaard
Journal:  Intern Emerg Med       Date:  2022-05-20       Impact factor: 5.472

Review 2.  Comorbid obstructive sleep apnoea and chronic obstructive pulmonary disease and the risk of cardiovascular disease.

Authors:  Walter T McNicholas
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 3.  Chronic obstructive pulmonary disease: moving from symptom relief to mortality reduction.

Authors:  Alessandro Celi; Manuela Latorre; Pierluigi Paggiaro; Riccardo Pistelli
Journal:  Ther Adv Chronic Dis       Date:  2021-05-13       Impact factor: 5.091

4.  β-blockers in exacerbations of COPD: feasibility of a randomised controlled trial.

Authors:  Catherina L Chang; Conroy Wong; Lutz Beckert; Eskandarain Shafuddin; Richard Beasley; Robert Young; Robert J Hancox
Journal:  ERJ Open Res       Date:  2017-01-17

Review 5.  Impact and prevention of severe exacerbations of COPD: a review of the evidence.

Authors:  David Mg Halpin; Marc Miravitlles; Norbert Metzdorf; Bartolomé Celli
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-05

6.  C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations.

Authors:  Yu-Wei Roy Chen; Virginia Chen; Zsuzsanna Hollander; Jonathon A Leipsic; Cameron J Hague; Mari L DeMarco; J Mark FitzGerald; Bruce M McManus; Raymond T Ng; Don D Sin
Journal:  PLoS One       Date:  2017-03-22       Impact factor: 3.240

Review 7.  Defining the relationship between COPD and CVD: what are the implications for clinical practice?

Authors:  Ann D Morgan; Rosita Zakeri; Jennifer K Quint
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

8.  Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission.

Authors:  Wiebke Bartels; Simon Adamson; Lisa Leung; Don D Sin; Stephan F van Eeden
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-05-23

9.  Beta-blocker under-use in COPD patients.

Authors:  Kuan Pin Lim; Sarah Loughrey; Michael Musk; Melanie Lavender; Jeremy P Wrobel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-17

Review 10.  Management of cardiovascular comorbidities in chronic obstructive pulmonary disease patients.

Authors:  Zaurbek Aisanov; Nikolai Khaltaev
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.